Literature DB >> 14714894

Thomsen-Friedenreich antigen: the "hidden" tumor antigen.

S Goletz1, Y Cao, A Danielczyk, P Ravn, U Schoeber, U Karsten.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14714894     DOI： 10.1007/978-1-4615-0065-0_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  12 in total

1.  Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells.

Authors:  Wei-Ming Lin; Uwe Karsten; Steffen Goletz; Ruo-Chuan Cheng; Yi Cao
Journal:  Int J Exp Pathol       Date:  2010-11-11       Impact factor: 1.925

2.  Sialylation of Thomsen-Friedenreich antigen is a noninvasive blood-based biomarker for GNE myopathy.

Authors:  Petcharat Leoyklang; May Christine Malicdan; Tal Yardeni; Frank Celeste; Carla Ciccone; Xueli Li; Rong Jiang; William A Gahl; Nuria Carrillo-Carrasco; Miao He; Marjan Huizing
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

3.  Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen.

Authors:  Christian Schindlbeck; Udo Jeschke; Sandra Schulze; Uwe Karsten; Wolfgang Janni; Brigitte Rack; Harald Sommer; Klaus Friese
Journal:  Histochem Cell Biol       Date:  2005-05-12       Impact factor: 4.304

4.  Binding of galectin-1 (gal-1) to the Thomsen-Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody.

Authors:  Udo Jeschke; Uwe Karsten; Irmi Wiest; Sandra Schulze; Christina Kuhn; Klaus Friese; Hermann Walzel
Journal:  Histochem Cell Biol       Date:  2006-04-11       Impact factor: 4.304

5.  Expression of MUC1 and CD176 (Thomsen-Friedenreich antigen) in papillary thyroid carcinomas.

Authors:  Xiang-xiang Zhan; Bing Zhao; Chang Diao; Yi Cao; Ruo-chuan Cheng
Journal:  Endocr Pathol       Date:  2015-03       Impact factor: 3.943

6.  CD176 single-chain variable antibody fragment inhibits the adhesion of cancer cells to endothelial cells and hepatocytes.

Authors:  Jiangnan Liu; Bin Yi; Zhe Zhang; Yi Cao
Journal:  Front Med       Date:  2016-04-18       Impact factor: 4.592

7.  The human endometrium expresses the glycoprotein mucin-1 and shows positive correlation for Thomsen-Friedenreich epitope expression and galectin-1 binding.

Authors:  Udo Jeschke; Hermann Walzel; Ioannis Mylonas; Panos Papadopoulos; Naim Shabani; Christina Kuhn; Sandra Schulze; Klaus Friese; Uwe Karsten; David Anz; Markus S Kupka
Journal:  J Histochem Cytochem       Date:  2009-06-08       Impact factor: 2.479

8.  Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients.

Authors:  Sabine Heublein; Doris Mayr; Markus Egger; Uwe Karsten; Steffen Goletz; Martin Angele; Julia Gallwas; Udo Jeschke; Nina Ditsch
Journal:  J Exp Clin Cancer Res       Date:  2015-05-19

9.  What makes cancer stem cell markers different?

Authors:  Uwe Karsten; Steffen Goletz
Journal:  Springerplus       Date:  2013-07-04

10.  Preclinical Analysis of JAA-F11, a Specific Anti-Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging.

Authors:  Loukia G Karacosta; John C Fisk; Joseph Jessee; Swetha Tati; Bradley Turner; Diala Ghazal; Rachel Ludwig; Holly Johnson; Julia Adams; Munawwar Sajjad; Steven Koury; Rene Roy; James R Olson; Kate Rittenhouse-Olson
Journal:  Transl Oncol       Date:  2018-02-22       Impact factor: 4.243
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.